Treatment of sickle cell anemia crises with fructose-1, 6-diphos

Details Treatment of sickle cell anemia crises with fructose-1, 6-diphos Treatment of sickle cell anemia crises with fructose-1, 6-diphos

1997-10-03

2000-06-13

Azpuru, Carlos

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

A61F 202

Patent

active

060746580

ABSTRACT:
Fructose-1,6-diphosphate (FDP) has been shown, in double-blinded controlled clinical trials on patients with sickle cell anemia, to substantially reduce the pain suffered by such patients during the recurrent ischemic crises that are caused by red blood cell sickling. Tests on patients who have been hospitalized for such crises demonstrated that when they received an intravenous injection of FDP, they reported substantially lower pain levels during their hospital stays than control groups that received identical treatment without any FDP. Apparently, FDP has never previously been used or even tested in human clinical trials, to treat sickle cell anemia. In addition, FDP has never previously been reported to have any analgesic (pain-reducing) activity.

REFERENCES:
patent: 4530902 (1985-07-01), Perri et al.
patent: 4546095 (1985-10-01), Markov
patent: 4703040 (1987-10-01), Markov
patent: 4870057 (1989-09-01), Chiapparelli et al.
patent: 5039665 (1991-08-01), Markov
patent: 5094947 (1992-03-01), Nakajima et al.
patent: 5434255 (1995-07-01), Katayama et al.
patent: 5506210 (1996-04-01), Parish et al.
Angelos, M.G., et al, "Fructose-1,6-diphosphate fails to limit early myocardial infarction size in a canine model," Ann. Emerg. Med. 22: 171-177 (1993).
Brunswick, R., et al, "Preservation of myocardium by infusion of fructose diphosphate following coronary occlusion,"abstract, Am J Cardiol 49: 1008 (1982).
Cargnoni, A., et al, "Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate," Cardiovasc Drugs Ther 6: 209-17 (1992).
Colomer, D., et al, "Erythrocyte fructose 2,6-bisphosphate content in congenital hemolytic anemias" (abstract), Hemoglobin 15: 517-23 (1991).
Conti, V.R., et al, "Metabolic and functional effects of carbohydrae substrate with single-dose and multiple-dose potassium cardioplegia," Ann. Thoracic Surg. 36: 320-327 (1983).
Eddy, L.J., et al, "Lack of a direct metabolic effect of fructose, 1,6-diphosphate in ischemic myocardium," Am J Physiol 241: H576-83 (1995).
"Esafosfina" sales brochure (Biomedica Foscama; Ferentino, Italy, 1994.
Farias, L.A., et al, "Effects of fructose-1,6-diphosphate, glucose and saline on cardiac resuscitation," Anesthesiology 65: 595-601 (1986).
Granot, H., et al, "Successful treatment of irreversible hemorrhagic shock in dogs with fructose-1,6 diphosphate and dichloroacetate," Circ Shock 163-73 (1985).
Hassinen, I.E., et al, "Mechanism of the effect of exogenous FDP on myocardial energy metabolism," Circulation 83: 584-593 (1991).
Lazzarino G., et al, "Protective effects of exogenously administered fructose-1,6-diphosphate from ischemia reperfusion damage induced on isolated rat heart," Ital J Biochem 38: 251A-253A (1989).
Lazzarino, G., et al, "Ischemia and reperfusion: effect of fructose-1,6-bisphosphate," Free Radic Res Commun 16: 325-39 (1992).
Marchionni, N., et al, "Hemodynamic and electrocardio-graphic effects of fructose-1,6-diphosphate in acute myocardial infarction," Am J Cardiol 56: 266-269 (1985).
Markov, A.K., et al, "Improvement of hemodynamics and pulmonary function following fructose 1-6 diphosphate administration in ARDS patients," Microcirculation 1: 173-178 (1987).
Markov, A.K., et al "Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia," Am Heart J 100: 639-46 (1980).
Markov, A.K., "Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations," Ann Emerg Med 15: 1470-7 (1986).
Markov, A.K., et al, "Increasing survival of dogs subjected to hemorrhaic shock by administration of fructose 1-6 diphosphate," Surgery 102: 515-27 (1987).
Pasque, M.K., et a, "Metabolic intervention to affect myocardinal recovery following ischemia," Annals of Surgery 200: 1-12 (1984).
Sernov, L.N., et al, "The characteristics of the cardioprotective action of fructose-1,6-diphosphate," Biull Eksp Biol Med 111: 172-3 (1991) (abstract).
Sernov, L.N., et al, "The antiacidotic and cardio-protective effects of fructose-1,6-diphosphate and dehydroascorbic acid," Farmakol Toksikol 54:24-26 (1991) (abstract).
Sernov, L.N., et al, "A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents," Eksp Klin Farmakol 55:13-15 (1992) (abstract).
Stryer, L., Biochemistry, 2nd ed., pp. 266-267 (Freeman & Co., San Francisco, 1981).
Zhang, J.N., et al, "Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock," Cardiovasc Res 22: 927-32 (1988).

Affiliated with

Also associated with

Rating

Treatment of sickle cell anemia crises with fructose-1, 6-diphos does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of sickle cell anemia crises with fructose-1, 6-diphos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sickle cell anemia crises with fructose-1, 6-diphos will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2066338